comparemela.com
  1. Home
  2. Live Updates
  3. Unresponsivenon Muscle Invasive Bladder Cancer - Breaking News

Latest Breaking News On - Unresponsivenon muscle invasive bladder cancer - Page 1 : comparemela.com

Johnson & Johnson : Results from Phase 2 THOR-2 Study Show Improved Rates of Recurrence-Free Survival in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor -October 23, 2023 at 07:22 am EDT

News Release Media Contacts: Suzanne Frost +1 416-317-0304 Brian Kenney +1 215-620-0111 .

United kingdomJames wf cattoIndianj urolClin urolObrian kenneyKiran patelJnjinnovmedand janssenExchange commissionDrug administrationClinical developmentCompanies of johnsonEuropean society for medical oncologyDepartment of oncologyEuropean society for medical oncology congressNone of janssen research developmentJanssen research development

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.